{
    "relation": [
        [
            "Name",
            "Vanguard Total Stock Market Index Fund",
            "Swedbank Robur Medica",
            "Vanguard Institutional Total Stock Market Index Fund",
            "Rhenman & Partners Fund - Healthcare Equity L/S",
            "Vanguard Extended Market Index Fund",
            "Principal Investors - Small Cap Blend Fund",
            "BlackRock Small Cap Growth Equity Portfolio",
            "Bridgeway Ultra Small Company Market Fund",
            "CS Investment Funds 5 - (Lux) Biotechnology Equity Fund",
            "Fidelity Spartan Extended Market Index Fund"
        ],
        [
            "Shares Held",
            "183.44K",
            "171.23K",
            "136.03K",
            "133.54K",
            "126.32K",
            "103.49K",
            "80.75K",
            "63.7K",
            "40K",
            "35.75K"
        ],
        [
            "% Outstanding",
            "0.9%",
            "0.84%",
            "0.67%",
            "0.66%",
            "0.62%",
            "0.51%",
            "0.4%",
            "0.31%",
            "0.2%",
            "0.18%"
        ],
        [
            "Change in Shares",
            "0",
            "0",
            "0",
            "25K",
            "780",
            "4.83K",
            "-1.62K",
            "0",
            "0",
            "0"
        ],
        [
            "% of Assets",
            "0%",
            "0.09%",
            "0%",
            "0.11%",
            "0%",
            "0.1%",
            "0.05%",
            "0.07%",
            "0.09%",
            "0%"
        ],
        [
            "As Of Date",
            "06/30/15",
            "04/30/15",
            "06/30/15",
            "12/31/14",
            "06/30/15",
            "03/31/15",
            "06/30/15",
            "03/31/15",
            "05/29/15",
            "05/31/15"
        ]
    ],
    "pageTitle": "BIND Stock Price & News - BIND Therapeutics Inc. - Barron's",
    "title": "",
    "url": "http://online.barrons.com/quote/stock/BIND",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 1,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988840.31/warc/CC-MAIN-20150728002308-00328-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 182410867,
    "recordOffset": 182394901,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{30800=All of the mutual fund and ETF information contained in this display was supplied by Lipper, A Thomson Reuters Company, subject to the following: Copyright 2015 \u00a9 Thomson Reuters. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon., 31448=Fundamental company data and analyst estimates provided by FactSet. Copyright 2015 FactSet Research Systems Inc. All rights reserved., 21646=Copyright 2015 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals}",
    "textBeforeTable": "Direct Holders Institutional Mutual Funds Major Holders May 7, 2015BIND Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate UpdatePR Newswires Jun 22, 2015BIND Therapeutics Appoints Andrew Hirsch as President and Chief Executive OfficerPR Newswires Jun 23, 2015BIND Therapeutics Announces FDA Authorization of First-in-Human Clinical Trial with AstraZeneca's Aurora B Kinase Inhibitor Accurin AZD2811PR Newswires Jun 23, 2015BIND Therapeutics and Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin(TM) Nanoparticle Using Manocept(TM) Macrophage Targeting PlatformPR Newswires Jun 23, 2015BIND Therapeutics to Present at JMP Securities Life Sciences Conference 2015PR Newswires Jul 28, 2015BIND Therapeutics to Report Second Quarter 2015 Financial Results on August 6, 2015PR Newswires Jul 2, 2014Synnex shares decline as outlook edges earningsMarketWatch.com Jul 3, 2014Stocks to Watch: Lululemon, Bind Therapeutics, Regado BiosciencesWSJ Blogs Jul 3, 2014PetSmart gains on Jana stake; Lorillard ralliesMarketWatch.com Oct 29, 2014",
    "textAfterTable": "Name Shares Held % Outstanding Change in Shares % of Assets As Of Date Heights Capital Management, Inc. 591.01K 2.9% 591.01K 0.12% 03/31/15 The Vanguard Group, Inc. 427.7K 2.1% 244.42K 0% 03/31/15 Principal Global Investors LLC 300K 1.47% -2.17K 0% 03/31/15 Rhenman & Partners Asset Management AB 133.54K 0.66% 0 0.1% 03/31/15 Renaissance Technologies LLC 108.37K 0.53% 108.37K 0% 03/31/15 BlackRock Advisors LLC 106.01K 0.52% 0 0% 03/31/15 Credit Suisse Securities (USA) LLC (Broker) 80.36K 0.39% -11.55K 0% 03/31/15 Bridgeway Capital Management, Inc. 63.7K 0.31% 0 0.01% 03/31/15 Geode Capital Management LLC 50.98K 0.25% 22.18K 0% 03/31/15 Spark Investment Management LLC 46.7K 0.23% -9.2K 0.04% 03/31/15 Name Shares Held As Of Date Polaris Partners 2.02M 03/31/15 Flagship Ventures 1.56M 03/31/15 RUSNANO Projects 1.49M 03/31/15 David Hamilton Koch 1.4M 03/31/15 ARCH Venture Partners LLC 825.75K 12/31/14 Robert S. Langer 723.42K 06/9/15 Scott Minick 440.65K 03/31/15 Andrew J. Hirsch 31.29K 06/22/15 Daniel Koerwer 7.63K 03/7/15 Amir H. Nashat 0 06/9/15 Copyright",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}